Adaptive Biotechnologies Corp. (ADPT)
14.86
-1.07
(-6.72%)
USD |
NASDAQ |
Mar 06, 16:00
14.98
+0.12
(+0.81%)
After-Hours: 20:00
Adaptive Biotechnologies Cash from Investing (TTM) : 37.95M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Pfizer Inc. | -1.351B |
| Gilead Sciences, Inc. | -4.793B |
| Regeneron Pharmaceuticals, Inc. | -629.10M |
| Recursion Pharmaceuticals, Inc. | -16.87M |
| Arcellx, Inc. | 86.30M |